Product
LYN-005
2 clinical trials
2 indications
Indication
SchizophreniaIndication
Schizoaffective DisorderClinical trial
A Multi Dose, Open-Label, Parallel-Group Study to Evaluate the PK and Safety/Tolerability of Long-Acting Oral Risperidone (LYN-005) in Participants With Schizophrenia or Schizoaffective DisorderStatus: Completed, Estimated PCD: 2023-11-03
Clinical trial
A Multiple Dose Study to Assess the Safety, Tolerability and Pharmacokinetics of Risperidone Extended Release Capsules in Subjects With Schizophrenia, Schizoaffective DisorderStatus: Completed, Estimated PCD: 2020-12-22